McKesson and CD&R near $5bn-plus deal to buy infusion services provider

🌐 Financial Times (United Kingdom) —

AI Summary

McKesson and private equity firm Clayton, Dubilier & Rice are nearing a deal valued at more than $5 billion to acquire infusion services provider Option Care Health. The potential buyout is described as the latest acquisition targeting an undervalued healthcare services company.

Acquisition of Option Care Health would be the latest buyout of an undervalued healthcare services company

Markets Deals Health McKesson Clayton Dubilier & Rice Option Care Health acquisition private equity infusion services healthcare

Read original source →